BacTech Closes Debenture Financing
14 Octobre 2010 - 9:14PM
Marketwired
BacTech Mining Corporation ("BacTech" or the "Company") (TSX
VENTURE: BM) announces that it has closed the private placement of
units announced on September 7, 2010 for gross proceeds of $430,000
(the "Offering"). Each unit is comprised of a $10,000 unsecured
convertible debenture, maturing on October 13, 2011 (the "Maturity
Date"), and 100,000 warrants. Each warrant entitles the holder to
acquire one common share of the Company at an exercise price of
$0.12 until October 13, 2011. The securities issued in connection
with the private placement are subject to a statutory four-month
hold period that expires February 14, 2011.
The convertible debentures may be converted by the holders at
any time at a price of $0.10 per common share (the "Conversion
Price"). In the event that the closing price of the Company's
common shares on the TSXV is at or greater than $0.15, the Company
shall have the right, in its sole discretion, to redeem the
convertible debentures through the issuance of common shares at the
Conversion Price. The interest rate on the convertible debentures
will be 1.5% per month, which shall be paid semi-annually. The
private placement is subject to requisite regulatory approval,
including the final approval of the TSX Venture Exchange. The
proceeds will be used for ongoing project evaluation and working
capital.
The Company also announces that it will mail the Management
Information Circular on October 22 to shareholders of record at
September 27. Shareholders will be asked to vote on the Company's
proposed Plan of Arrangement at a Special Shareholders Meeting. The
date for this meeting has been changed to November 12 from October
28, as originally announced in a news release dated September
7.
BACTECH PROFILE
BacTech owns patented bacterial oxidation technology for the
treatment of refractory ores and concentrates to enhance the
recovery of gold, silver and base metals. The Company's initial
focus is the acquisition of equity positions in projects amenable
to bioleaching.
Shares outstanding 132,943,039
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: BacTech Mining Corporation Ross Orr President &
CEO 416-813-0303 ext 222 info@bactech.com www.bactech.com
BC Moly (TSXV:BM)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
BC Moly (TSXV:BM)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
Real-Time news about BC Moly Ltd (TSX Venture Exchange): 0 recent articles
Plus d'articles sur BacTech Mining Corporation